$KTEL
KonaTel, Inc.

2024 Q4 Form 10-Q Financial Statement

#000151597124000088 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $3.148M
YoY Change -32.86%
Cost Of Revenue $2.439M
YoY Change -28.78%
Gross Profit $709.4K
YoY Change -43.89%
Gross Profit Margin 22.53%
Selling, General & Admin $1.634M
YoY Change 73.0%
% of Gross Profit 230.39%
Research & Development $259.8K
YoY Change 40.19%
% of Gross Profit 36.63%
Depreciation & Amortization $2.450K
YoY Change -431.08%
% of Gross Profit 0.35%
Operating Expenses $1.897M
YoY Change 67.38%
Operating Profit -$1.187M
YoY Change -1005.84%
Interest Expense $407.00
YoY Change -99.81%
% of Operating Profit
Other Income/Expense, Net -$1.694K
YoY Change -99.31%
Pretax Income -$1.189M
YoY Change 950.09%
Income Tax
% Of Pretax Income
Net Earnings -$1.189M
YoY Change 950.13%
Net Earnings / Revenue -37.76%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 43.50M shares 43.49M shares
Diluted Shares Outstanding 43.49M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.688M
YoY Change 103.33%
Cash & Equivalents $2.688M
Short-Term Investments
Other Short-Term Assets $1.302M
YoY Change
Inventory $360.1K
Prepaid Expenses $133.2K
Receivables $1.860M
Other Receivables $0.00
Total Short-Term Assets $6.344M
YoY Change 90.89%
LONG-TERM ASSETS
Property, Plant & Equipment $16.84K
YoY Change -38.27%
Goodwill
YoY Change
Intangibles $674.7K
YoY Change 6.38%
Long-Term Investments
YoY Change
Other Assets $74.54K
YoY Change 0.0%
Total Long-Term Assets $766.1K
YoY Change -35.52%
TOTAL ASSETS
Total Short-Term Assets $6.344M
Total Long-Term Assets $766.1K
Total Assets $7.110M
YoY Change 57.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.176M
YoY Change 60.04%
Accrued Expenses $125.4K
YoY Change 0.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.301M
YoY Change -42.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $248.8K
YoY Change -31.52%
Total Long-Term Liabilities $248.8K
YoY Change -31.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.301M
Total Long-Term Liabilities $248.8K
Total Liabilities $3.550M
YoY Change -41.78%
SHAREHOLDERS EQUITY
Retained Earnings -$6.454M
YoY Change -38.81%
Common Stock $43.49K
YoY Change 1.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.560M
YoY Change
Total Liabilities & Shareholders Equity $7.110M
YoY Change 57.6%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.189M
YoY Change 950.13%
Depreciation, Depletion And Amortization $2.450K
YoY Change -431.08%
Cash From Operating Activities -$992.9K
YoY Change -644.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -992.9K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -992.9K
YoY Change -632.42%
FREE CASH FLOW
Cash From Operating Activities -$992.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000845819
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-10171
dei Entity Registrant Name
EntityRegistrantName
KonaTel, Inc.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0973608
dei Entity Address Address Line1
EntityAddressAddressLine1
500 N. Central Expressway
dei Entity Address Address Line2
EntityAddressAddressLine2
 Ste. 202
dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
dei City Area Code
CityAreaCode
214
dei Local Phone Number
LocalPhoneNumber
323-8410
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43503658 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
777103 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1860328 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1496799 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
360061 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1229770 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133235 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
129706 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1301876 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
6343803 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3633378 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16836 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24184 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
323468 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
351240 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
443328 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74543 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74543 usd
CY2024Q3 us-gaap Assets
Assets
7109890 usd
CY2023Q4 us-gaap Assets
Assets
4809684 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3175696 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3709691 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125364 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127716 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
3424832 usd
us-gaap Cost Of Revenue
CostOfRevenue
10390841 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
709372 usd
us-gaap Net Income Loss
NetIncomeLoss
5784473 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3301060 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7492578 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
330511 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
248826 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
330511 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7823089 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
43489 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
43146 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9970733 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9182140 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6454218 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12238691 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3560004 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3013405 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7109890 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4809684 usd
CY2024Q3 us-gaap Revenues
Revenues
3148409 usd
CY2023Q3 us-gaap Revenues
Revenues
4689001 usd
us-gaap Revenues
Revenues
13127425 usd
us-gaap Revenues
Revenues
13322146 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
2439037 usd
us-gaap Cost Of Revenue
CostOfRevenue
10282046 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1264169 usd
us-gaap Gross Profit
GrossProfit
2736584 usd
us-gaap Gross Profit
GrossProfit
3040100 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1316381 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
686560 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4108020 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2933409 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1179 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1242 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4143 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4563 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1448 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
214 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
113546 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
435960 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
576964 usd
CY2024Q3 us-gaap Other General Expense
OtherGeneralExpense
50292 usd
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
53814 usd
us-gaap Other General Expense
OtherGeneralExpense
160410 usd
us-gaap Other General Expense
OtherGeneralExpense
162889 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2449 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3088 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9264 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54006 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35459 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
159974 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120103 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
24629 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36633 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
85657 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
120640 usd
CY2024Q3 ktel Application Development Costs
ApplicationDevelopmentCosts
259836 usd
CY2023Q3 ktel Application Development Costs
ApplicationDevelopmentCosts
185350 usd
ktel Application Development Costs
ApplicationDevelopmentCosts
853719 usd
ktel Application Development Costs
ApplicationDevelopmentCosts
628508 usd
CY2024Q3 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
93385 usd
CY2023Q3 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
17214 usd
us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
208442 usd
us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
49225 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1896592 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1133106 usd
us-gaap Operating Expenses
OperatingExpenses
6025121 usd
us-gaap Operating Expenses
OperatingExpenses
4605779 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
131063 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3288537 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1565679 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9247726 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
209991 usd
us-gaap Interest Expense
InterestExpense
104737 usd
us-gaap Interest Expense
InterestExpense
551123 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1287 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34288 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69979 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-133831 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1694 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-244279 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9073010 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684954 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2024Q3 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2023Q3 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2688303 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3655171 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248826 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3549886 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43472950 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43472950 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43145720 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43145720 shares
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200 usd
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
94435 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7348 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1187220 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
407 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1188914 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-113216 usd
us-gaap Net Income Loss
NetIncomeLoss
5784473 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43485560 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42707808 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43385493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42658697 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43485560 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42707808 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43698965 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42658697 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3013405 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
747686 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41250 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3560004 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4447978 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300940 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1188914 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3560004 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85133 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123751 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1586386 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1316984 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-197436 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41250 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-113216 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1586386 usd
us-gaap Net Income Loss
NetIncomeLoss
5784473 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7348 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9264 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9247726 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-49579 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-131141 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
1448 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
214 usd
us-gaap Share Based Compensation
ShareBasedCompensation
747686 usd
us-gaap Share Based Compensation
ShareBasedCompensation
85133 usd
ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
82500 usd
ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-92088 usd
ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-101568 usd
ktel Change In Lease Liability
ChangeInLeaseLiability
-84037 usd
ktel Change In Lease Liability
ChangeInLeaseLiability
-87930 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
364977 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-256189 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-869709 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
152848 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
305405 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7448 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1000000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-533995 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
635335 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3983809 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1197515 usd
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
9558509 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9558509 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3704750 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
77250 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41250 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41250 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3663500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
464000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1911200 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-733515 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
777103 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2055634 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2688303 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1322119 usd
us-gaap Interest Paid Net
InterestPaidNet
54750 usd
us-gaap Interest Paid Net
InterestPaidNet
167900 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1188914 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-113216 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43485560 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42707808 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43485560 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42707808 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Net Income Loss
NetIncomeLoss
5784473 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43385493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42658697 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
313472 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43698965 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42658697 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zFEYuW5pPbU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of receivables, cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All cash and cash equivalents are held at high credit financial institutions. These deposits are generally insured under the FDIC’s deposit insurance coverage; however, from time to time, the deposit levels may exceed FDIC coverage levels.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91E_eus-gaap--TradeAccountsReceivableMember_ziZP7acpkiri" style="display: none">Trade Account Receivables</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_913_eus-gaap--CustomerConcentrationRiskMember_zifOLZoti1r" style="display: none">Customer Concentration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_911_eus-gaap--SalesRevenueNetMember_zQ8d8TOmdYA9" style="display: none">Sales Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a concentration of risk with respect to trade receivables from customers and cellular providers. As of September 30, 2024, the Company had a significant concentration of receivables (defined as customers whose receivable balances are greater than 10% of total receivables) due from two (2) customers in the amount of $<span id="xdx_900_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zYApamn1OnTf" title="Receivables, concentration">1,369,032</span> or <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zBoHK1Zx4sxk" title="Concentration risk">73.3</span>%, and $<span id="xdx_906_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zEINQcHgQnd6" title="Receivables, concentration">192,508</span> or <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zsE1a0jVYIdl" title="Concentration risk">10.3</span>%. It should be noted that the largest customer is the State of California, and the second largest customer is the federal government, as administered by the Universal Service Administrative Company (“USAC”), under the authority of the FCC. As of December 31, 2023, the Company had a significant concentration of receivables from two (2) customers in the amounts of $<span id="xdx_907_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zHEtYOmI6n8k" title="Receivables, concentration">1,024,308</span> or <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zsNWzHMUK2Nh" title="Concentration risk">68.5</span>%, and $<span id="xdx_907_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zEiKIKFaSV9b" title="Receivables, concentration">285,536</span> or <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zB9clkkVVtW8" title="Concentration risk">19.0</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Net Income Loss
NetIncomeLoss
5784473 usd
us-gaap Net Income Loss
NetIncomeLoss
-2250633 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6454218 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
360061 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1229770 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
444775 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
437427 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16836 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24184 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company had two (2) properties with lease terms in excess of one (1) year. Of these two (2) leases, one (1) lease expires in 2026, and one (1) lease expires in 2030
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
374190 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
39000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
129543 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
65967 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
54000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
54000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
90000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
432510 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
58320 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
374190 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125364 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248826 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P56M9D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0701 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
125917 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
128582 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
323468 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
323468 usd
CY2024Q3 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2023Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2024Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
323468 usd
CY2023Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
323468 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
351240 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
443328 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
674708 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1077579 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021Q4 us-gaap Liabilities Subject To Compromise Income Tax Contingencies
LiabilitiesSubjectToCompromiseIncomeTaxContingencies
7000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 number
us-gaap Revenues
Revenues
13127425 usd
us-gaap Gross Profit
GrossProfit
2736584 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7348 usd
CY2024Q3 us-gaap Revenues
Revenues
3148409 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
709372 usd
CY2024Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2449 usd
us-gaap Revenues
Revenues
13322146 usd
us-gaap Gross Profit
GrossProfit
3040100 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
9264 usd
CY2023Q3 us-gaap Revenues
Revenues
4689001 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1264169 usd
CY2023Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3088 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
747686 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
85133 usd
CY2024Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300940 usd
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
-197436 usd
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
2288689 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M8D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
872463 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.47
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
425000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.41
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5675000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.78
ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y6M7D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
313472 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M14D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001515971-24-000088-index-headers.html Edgar Link pending
0001515971-24-000088-index.html Edgar Link pending
0001515971-24-000088.txt Edgar Link pending
0001515971-24-000088-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
exhibit99.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ktel-20240930.xsd Edgar Link pending
ktel10q093024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
ktel-20240930_cal.xml Edgar Link unprocessable
ktel-20240930_def.xml Edgar Link unprocessable
ktel-20240930_pre.xml Edgar Link unprocessable
ktel10q093024_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ktel-20240930_lab.xml Edgar Link unprocessable